论文部分内容阅读
As we know, gold standard therapy for hepatocellular carcinoma (HCC) with underlying liver disease is orthotopic liver transplantation (OLT) given that the malignant burden is within certain criteria. Prior to 1996, outcomes were quite poor with 5-year survival reported as low as 20％ (1) with transplants being performed without impedance for all tumors of all sizes.